Literature DB >> 22707255

Reinstatement of cocaine seeking in rats by the pharmacological stressors, corticotropin-releasing factor and yohimbine: role for D1/5 dopamine receptors.

Z J Brown1, D A Kupferschmidt, Suzanne Erb.   

Abstract

RATIONALE: Two pharmacological stressors commonly used in the study of stress-induced reinstatement of drug seeking are central injections of the stress peptide, corticotropin-releasing factor (CRF), and systemic administration of the α(2)-adrenoceptor antagonist, yohimbine. Despite the widespread use of these stressors, the neurochemical systems mediating their ability to reinstate cocaine-seeking behaviour have not been fully characterized.
OBJECTIVE: The present study was designed to characterize the role, specifically, of dopamine transmission in the reinstating effects of CRF and yohimbine on cocaine seeking.
METHODS: Male Long-Evans rats were trained to self-administer cocaine (0.23 mg/kg/infusion) for 8-10 days. Subsequently, responding for drug was extinguished, and tests for CRF- (0.5 μg; i.c.v.) and yohimbine-induced (1.25 mg/kg; i.p.) reinstatement were conducted following pretreatment with the dopamine D1/5 receptor antagonists, SCH23390 (0.05, 0.1 mg/kg; i.p.) and/or SCH31966 (0.2 mg/kg; i.p.), and the D2/3 receptor antagonist, raclopride (0.25, 0.5 mg/kg; i.p.).
RESULTS: Pretreatment with SCH23390, but not raclopride, blocked CRF-induced reinstatement of cocaine seeking. Pretreatment with SCH23390 and SCH31966, but not raclopride, blocked yohimbine-induced reinstatement of cocaine seeking.
CONCLUSIONS: These findings demonstrate that transmission at D1/5, but not D2/3, receptors mediates the reinstatement of cocaine seeking induced by CRF and yohimbine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22707255     DOI: 10.1007/s00213-012-2772-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  54 in total

1.  Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.

Authors:  M J Millan; A Newman-Tancredi; V Audinot; D Cussac; F Lejeune; J P Nicolas; F Cogé; J P Galizzi; J A Boutin; J M Rivet; A Dekeyne; A Gobert
Journal:  Synapse       Date:  2000-02       Impact factor: 2.562

2.  Activation of central neurotensin receptors reinstates cocaine seeking in the rat: modulation by a D1/D5, but not D2/D3, receptor antagonist.

Authors:  Vanessa Lopak; Suzanne Erb
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

Review 3.  Understanding and preventing relapse.

Authors:  K D Brownell; G A Marlatt; E Lichtenstein; G T Wilson
Journal:  Am Psychol       Date:  1986-07

4.  Role of corticotropin-releasing factor in the median raphe nucleus in yohimbine-induced reinstatement of alcohol seeking in rats.

Authors:  A D Lê; Douglas Funk; Kathleen Coen; Zhaoxia Li; Yavin Shaham
Journal:  Addict Biol       Date:  2011-10-04       Impact factor: 4.280

5.  Role of dorsal medial prefrontal cortex dopamine D1-family receptors in relapse to high-fat food seeking induced by the anxiogenic drug yohimbine.

Authors:  Sunila G Nair; Brittany M Navarre; Carlo Cifani; Charles L Pickens; Jennifer M Bossert; Yavin Shaham
Journal:  Neuropsychopharmacology       Date:  2010-10-20       Impact factor: 7.853

6.  Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients.

Authors:  Susan M Stine; Steven M Southwick; Ismene L Petrakis; Thomas R Kosten; Dennis S Charney; John H Krystal
Journal:  Biol Psychiatry       Date:  2002-04-15       Impact factor: 13.382

7.  Behavioral and anatomical interactions between dopamine and corticotropin-releasing factor in the rat.

Authors:  Edward G Meloni; Lyle P Gerety; Allison T Knoll; Bruce M Cohen; William A Carlezon
Journal:  J Neurosci       Date:  2006-04-05       Impact factor: 6.167

8.  Yohimbine's anxiogenic action: evidence for noradrenergic and dopaminergic sites.

Authors:  A L Johnston; S E File
Journal:  Pharmacol Biochem Behav       Date:  1989-01       Impact factor: 3.533

9.  A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking.

Authors:  S Erb; J Stewart
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

10.  Infusion of the substance P analogue, DiMe-C7, into the ventral tegmental area induces reinstatement of cocaine-seeking behaviour in rats.

Authors:  Franca M Placenza; Paul J Fletcher; Susan Rotzinger; Franco J Vaccarino
Journal:  Psychopharmacology (Berl)       Date:  2004-05-27       Impact factor: 4.530

View more
  13 in total

Review 1.  Corticotropin releasing factor: a key role in the neurobiology of addiction.

Authors:  Eric P Zorrilla; Marian L Logrip; George F Koob
Journal:  Front Neuroendocrinol       Date:  2014-01-20       Impact factor: 8.606

Review 2.  Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress.

Authors:  John R Mantsch; David A Baker; Douglas Funk; Anh D Lê; Yavin Shaham
Journal:  Neuropsychopharmacology       Date:  2015-05-15       Impact factor: 7.853

3.  Reinstatement of Pavlovian responses to alcohol cues by stress.

Authors:  Anne Armstrong; Hailey Rosenthal; Nakura Stout; Jocelyn M Richard
Journal:  Psychopharmacology (Berl)       Date:  2022-10-13       Impact factor: 4.415

4.  Inactivation of the lateral habenula reduces anxiogenic behavior and cocaine seeking under conditions of heightened stress.

Authors:  Margaret J Gill; Shannon M Ghee; Stiles M Harper; Ronald E See
Journal:  Pharmacol Biochem Behav       Date:  2013-08-19       Impact factor: 3.533

5.  Differential effect of orexin-1 and CRF-1 antagonism on stress circuits: a fMRI study in the rat with the pharmacological stressor Yohimbine.

Authors:  Alessandro Gozzi; Stefano Lepore; Elena Vicentini; Emilio Merlo-Pich; Angelo Bifone
Journal:  Neuropsychopharmacology       Date:  2013-05-08       Impact factor: 7.853

6.  The pharmacological stressor yohimbine, but not U50,488, increases responding for conditioned reinforcers paired with ethanol or sucrose.

Authors:  Rayane I Tabbara; Arya Rahbarnia; Anh D Lê; Paul J Fletcher
Journal:  Psychopharmacology (Berl)       Date:  2020-08-25       Impact factor: 4.530

7.  Activation of peroxisome proliferator-activated receptor γ reduces alcohol drinking and seeking by modulating multiple mesocorticolimbic regions in rats.

Authors:  Yannick Fotio; Anna Maria Borruto; Federica Benvenuti; Gregory Demopulos; George Gaitanaris; Marisa Roberto; Roberto Ciccocioppo
Journal:  Neuropsychopharmacology       Date:  2020-07-01       Impact factor: 7.853

8.  The form of a conditioned stimulus can influence the degree to which it acquires incentive motivational properties.

Authors:  Paul J Meyer; Elizabeth S Cogan; Terry E Robinson
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

Review 9.  Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction?

Authors:  Kari A Johnson; David M Lovinger
Journal:  Front Cell Neurosci       Date:  2016-11-11       Impact factor: 5.505

10.  Inactivation of the nucleus accumbens core or medial shell attenuates reinstatement of sugar-seeking behavior following sugar priming or exposure to food-associated cues.

Authors:  Peagan Lin; Wayne E Pratt
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.